ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions. The green light ...

Positive study results in Phase 2 lead to a green light for the companies’ combination and plans to move their nasal spray ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

I used a five-point scale, with one being the faintest and five being the stinkiest. How Easy is it to Use? I also evaluated how easy each repellent was to apply. Easy spray-and-go applications ranked ...

STS101 nasal powder, DHE, delivers fast, lasting relief from cardinal migraine symptoms, including photophobia, phonophobia, ...